Trial Profile
Japanese Registry Study in Comparison Between Everolimus-eluting Stent and Sirolimus-eluting Stent for the Bifurcation Lesion
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms J-REVERSE
- 31 Dec 2010 New trial record